RB
Ritu Baral TD Cowen Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
15
Avg Return
Past Year
Past Year
39%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
90.9%
Neutral
9.1%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $306 |
7%
upside
| 1 | +15% |
0
%
| 9 Jan ‘26 10 days ago |
|
|
|
Buy
Initiated
| $67 |
88%
upside
| 1 | -10% |
0
%
| 5 Jan ‘26 14 days ago |
|
|
|
Buy
Maintained
| $241 |
49%
upside
| 3 | +4.3% |
0
%
| 18 Dec ‘25 1 month ago |
|
|
|
Buy
Maintained
| $133 |
33%
upside
| 2 | +158% |
0
%
| 16 Dec ‘25 1 month ago |
|
|
|
Buy
Upgraded
| $8 |
290%
upside
| 1 | -15% |
0
%
| 15 Dec ‘25 1 month ago |
|
|
|
Buy
Maintained
| $353 |
11%
upside
| 1 | +28% |
0
%
| 8 Dec ‘25 1 month ago |
|
|
|
Buy
Maintained
| $73 |
57%
upside
| 1 | +9.2% |
0
%
| 5 Dec ‘25 1 month ago |
|
|
|
Hold
Downgraded
| $74 |
2%
upside
| 1 | -2.9% |
–
| 29 Oct ‘25 2 months ago |
|